Cargando…
Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421491/ https://www.ncbi.nlm.nih.gov/pubmed/36049973 http://dx.doi.org/10.1016/j.medcli.2022.08.003 |
| _version_ | 1784777604194107392 |
|---|---|
| author | Arranz, Natàlia Fernández, Sara Bastida, Carla |
| author_facet | Arranz, Natàlia Fernández, Sara Bastida, Carla |
| author_sort | Arranz, Natàlia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9421491 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94214912022-08-30 Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient Arranz, Natàlia Fernández, Sara Bastida, Carla Med Clin (Barc) Letter to the Editor Elsevier España, S.L.U. 2022-12-23 2022-08-29 /pmc/articles/PMC9421491/ /pubmed/36049973 http://dx.doi.org/10.1016/j.medcli.2022.08.003 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Arranz, Natàlia Fernández, Sara Bastida, Carla Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient |
| title | Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient |
| title_full | Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient |
| title_fullStr | Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient |
| title_full_unstemmed | Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient |
| title_short | Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient |
| title_sort | use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421491/ https://www.ncbi.nlm.nih.gov/pubmed/36049973 http://dx.doi.org/10.1016/j.medcli.2022.08.003 |
| work_keys_str_mv | AT arranznatalia useofinsulinandheparininthemanagementofseverehypertriglyceridemiainacriticallyillpatient AT fernandezsara useofinsulinandheparininthemanagementofseverehypertriglyceridemiainacriticallyillpatient AT bastidacarla useofinsulinandheparininthemanagementofseverehypertriglyceridemiainacriticallyillpatient |